Editing for Purity
Secretome engineering eliminates unwanted proteins in CHO-based bioprocessing
Stephanie Sutton | | Quick Read
When CHO cells are used to produce recombinant-protein drugs, they can also produce many other unwanted proteins. Although these are removed during purification, they add to manufacturing costs and reduce efficiency. Researchers at the University of California, San Diego, and the Technical University of Denmark have published a paper showing how they used “multiplex secretome engineering” to increase recombinant protein production and purity (1).
The work builds on prior computational work showing that a relatively small number of unwanted proteins account for the majority of cell energy and resources (1). This inspired the researchers to eliminate the dominant contaminating proteins to free up cellular resources.
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.
- S Kol at al., “Multiplex secretome engineering enhances recombinant protein production and purity,” Nature Communications, 11 (2020).